NextCure Initiates Phase 1/2 Clinical Trial of NC762 for Solid Tumors,

“We are pleased to have initiated the clinical trial of our third product candidate,” said Michael Richman, NextCure’s president and chief executive …, “We are pleased to have initiated the clinical trial of our third product candidate,” said Michael Richman, NextCure’s president and chief executive …, Read More

Scroll to Top